MultiGEN Diagnostics, Inc. : Physicians

Friday, September 05, 2008 9:58:53 PM

MultiGEN Diagnostics Inc | Tel: (858)523-1313 Fax: (858)523-1677 | San Diego, CA

Home

Information for Clients

Tests Offered

Technology

FAQ

About Us

Information for Physicians:

Ideally all the potential pathogens causing a particular infectious syndrome should be identified in a single test, with ‘Gold-Standard’ accuracy, same-day reporting and at an affordable price.

Well, that ideal has finally been realized with MultiGEN Diagnostics, and your ability to diagnose and test infections vastly improved.

Using the well-documented ‘Gold-Standard’ accuracy of DNA sequencing, we are able to provide ‘Syndrome Driven Panels’ in a single test that screens for all the pathogens that can cause a particular syndrome regardless of whether they are bacteria, viruses, fungi or parasites. And we do all this with same-day reporting to better assist with the timely creation of an optimal treatment regime. The cost per reported result is significantly less than the cumulative cost of screening for all potential pathogens separately (as is presently the case).

MultiGEN Diagnostics is the very first laboratory to commercialize DNA sequencing for routine clinical diagnosis in infectious disease. Our patented MultiGEN technology sets a new benchmark in lab investigation and has substantial clinical advantages:

	•	Identification of any pathogen whether viral, bacterial, fungal or parasitic
	•	‘Gold Standard’ accuracy of DNA sequence-based microbial identification
	•	Same day reporting
	•	‘Syndrome Driven’ testing for any of the multiple pathogens that can cause a particular clinical syndrome in a single test panel
	•	Automatic sub-typing of pathogens leading to important epidemiologic data of value in outbreak investigations such as SARS, Avian ‘Flu, ‘Super Bugs’, Syphilis etc.
	•	Sample quality is much less of a problem than with traditional methods where pathogens must be alive in order for them to grow in culture

This all translates into a better, faster and more clinically relevant service than labs have traditionally been able to offer to clinicians. And we can do all of this at a significantly lower cumulative cost due to the ability of MultiGEN technology to detect multiple pathogens simultaneously in the same test.